Home/PMV Pharmaceuticals/David Mack, Ph.D.
DM

David Mack, Ph.D.

Co-founder, President and Chief Executive Officer

PMV Pharmaceuticals

PMV Pharmaceuticals Pipeline

DrugIndicationPhase
PC14586 (revetrectinib)Advanced solid tumors with p53 Y220C mutationPhase 1/2